All In MedTech

Device Trial Radar · NCT04884672

PMCF Study on SMILE Treatment of Myopia With and Without Astigmatism

Post-Market Clinical Follow-up Study on SMILE Treatment of Myopia With and Without Astigmatism by VISUMAX 800

Last checked: Nov 20, 2026Latest source record: Oct 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

237

Actual

Start

Jul 9, 2021

Primary completion

Mar 25, 2023

Study completion Mar 25, 2023

Sponsor

Lead sponsor
Carl Zeiss Meditec AGNot on our public-company list
Sponsor type
Industry
Collaborators
In Vitro Research Solutions Pvt Ltd (iVRS)
First posted
May 13, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this PMCF investigation is to systematically collect safety and effectiveness data with the VISUMAX 800 laser in clinical daily routine SMILE use for the purpose of post market surveillance.

Conditions

  • Myopia
  • Astigmatism

Interventions

  • SMILEDevice

    Small incision lenticule extraction, a refractive surgery procedure for the corrcetion of myopia with or without astigmatism

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Accuracy of manifest spherical equivalentTime frame: 1 week
  2. Accuracy of manifest spherical equivalentTime frame: 1 month
  3. Accuracy of manifest spherical equivalentTime frame: 3 months

12 more outcomes with a free account

Locations

5 sites in 4 countries. Site status is shown where the registry gives one.

  • Department of Clinical Medicine - Department of Ophthalmology

    Aarhus, Denmark

  • University Medical Center Universitätsklinikum Gießen Marburg

    Marburg, Germany

  • Smile Eyes Airport München

    München, Germany

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.